We are so excited to announce our partnership with [Flight for Every Mother](http://www.flightforeverymother.com/). Dr. Sophia Webster is a 21st century Amelia Earheart with a mission for mothers. She is a flying obstetrician/gynecologist making a 24 country flight piloting her own Cessna to deliver knowledge and supplies to obstetricians and midwives. And she leaves in August!
We love her approach because it is one part advocacy and two parts practicality. Maternova Research will be sending life-saving obstetric supplies including the non-pneumatic anti-shock garment. We’ll also be working with Dr. Webster on how best to communicate the steps involved in creating the lowest cost balloon tamponade on the planet—the condom balloon tamponade.
What is particularly exciting about this journey is that it allows all of us to receive feedback, in rapid succession from a range of obstetricians and midwives working in the most difficult settings to save lives. Dr. Webster will be raising awareness but she will also be teaching. The clinicians will have a chance to provide direct feedback on protocols and technologies. What set of interventions is most appropriate for massive bleeding and shock in their settings? What does the government recommend? What is the protocol for eclampsia? We look forward to amplifying these voices as the Flight for Every Mother happens.
We are raising funds for life-saving technologies to be carried by Dr. Webster and her team via our new non-profit affiliate,[(Maternova Research](http://maternova.net/announcing-maternova-research-non-profit-affiliate-maternova).
We are also using our networks to help Dr. Webster and her team find the best partners to visit during their journey. Please send us ideas!
The warming mattress (made up of strips of phase change material) can stay warm for 6 or more hours. It is a flexible mattress that can be used in conjunction with skin to skin contact or with Kangaroo Mother Care.
According to the American College of Obstetricians and Gynecologists (ACOG) and the International Federation of Gynecology and Obstetrics (FIGO), the administration of antenatal corticosteroids is recommended in women with a pregnancy between 24 and 34 weeks who are at risk of preterm birth within the next seven days.